FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Phenylephrine hydrochloride 10 mg/mL nasal solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely amphotericin B lipid complex 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely amphotericin B lipid complex 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Aminocaproic acid 250 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Aminocaproic acid 250 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution Has concentration strength denominator value False un Inferred relationship Some 2
    Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution Has concentration strength denominator value False un Inferred relationship Some 1
    Memantine hydrochloride 2 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Memantine hydrochloride 2 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Miconazole nitrate 40 mg/mL vaginal cream Count of base of active ingredient False un Inferred relationship Some
    Miconazole nitrate 40 mg/mL vaginal cream Has concentration strength denominator value False un Inferred relationship Some 1
    Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
    Dextran 40 100 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Dextran 40 100 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
    Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Phenylephrine hydrochloride 25 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Phenylephrine hydrochloride 25 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Difluprednate 500 microgram/mL eye suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Difluprednate 500 microgram/mL eye suspension Count of base of active ingredient False un Inferred relationship Some
    Morphine sulfate liposome 10 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Morphine sulfate liposome 10 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Miconazole nitrate 50 mg buccal tablet Count of base of active ingredient False un Inferred relationship Some
    Miconazole nitrate 50 mg buccal tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cimetidine 6 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pentastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pentastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 2
    Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Aprotinin 1.4 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Aprotinin 1.4 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Atropine sulfate 620 microgram/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Atropine sulfate 620 microgram/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Bendamustine hydrochloride 100 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Bendamustine hydrochloride 100 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely potassium gluconate 312 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely potassium gluconate 312 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength numerator value False un Inferred relationship Some 2
    Product containing precisely pentobarbital sodium 3.64 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely pentobarbital sodium 3.64 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely coal tar 300 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely coal tar 300 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Pentastarch 100 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Pentastarch 100 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Atropine sulfate 1 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Atropine sulfate 1 mg/mL eye solution Has concentration strength numerator value False un Inferred relationship Some 1
    Atropine sulfate 1 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ferric ion (as sodium ferric gluconate complex) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ferric ion (as sodium ferric gluconate complex) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Pentobarbital sodium 4 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Pentobarbital sodium 4 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Testosterone 30 mg buccal film Count of base of active ingredient False un Inferred relationship Some
    Testosterone 30 mg buccal film Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely glucose 600 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Cocaine hydrochloride 40 mg/mL cutaneous solution Count of base of active ingredient False un Inferred relationship Some
    Cocaine hydrochloride 40 mg/mL cutaneous solution Has concentration strength denominator value False un Inferred relationship Some 1
    Testosterone 10 mg/g cutaneous gel Count of base of active ingredient False un Inferred relationship Some
    Testosterone 10 mg/g cutaneous gel Has concentration strength denominator value False un Inferred relationship Some 1
    Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel Has concentration strength denominator value False un Inferred relationship Some 1
    Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely glucose 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely glucose 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Sulfadiazine 250 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Sulfadiazine 250 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Ascorbic acid 250 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Ascorbic acid 250 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Methylphenidate hydrochloride 10 mg chewable tablet Count of base of active ingredient False un Inferred relationship Some
    Methylphenidate hydrochloride 10 mg chewable tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Triclosan 20 mg/mL cutaneous solution Count of base of active ingredient False un Inferred relationship Some
    Triclosan 20 mg/mL cutaneous solution Has concentration strength denominator value False un Inferred relationship Some 1
    Loracarbef 40 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Loracarbef 40 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some

    Start Previous Page 192 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start